These cell lines included CCRF-CEM, CEM/ADR5000, HL60 and HL60AR leukemia cell lines, MDA-MB231 and MDA-MB231/BCRP breast adenocarcinoma cell line, HCT116 p53+/+ and HCT116 p53−/− colon carcinoma cell line, U87MG, and U87MG.ΔEGFR gliobastoma cell line, HepG2 hepatocarcinoma cell line and Mia Paca2 pancreatic cancer cell line [8, 10]. This evidence concerns the gene TP53 and colon carcinoma.